Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Decreases By 66.0%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 3,300 shares, a decrease of 66.0% from the February 28th total of 9,700 shares. Based on an average daily volume of 178,400 shares, the days-to-cover ratio is currently 0.0 days.

Tevogen Bio Trading Down 0.2 %

NASDAQ:TVGNW opened at $0.06 on Thursday. Tevogen Bio has a 1 year low of $0.01 and a 1 year high of $0.15. The firm’s fifty day simple moving average is $0.07 and its 200 day simple moving average is $0.06.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.